| 產(chǎn)品名稱 |
Streptococcus sp. |
| 商品貨號 |
B177750 |
| Application |
Production of a lytic enzyme from the lysate of phage (21597-B1) infected preparations Bacteriophage host |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties |
Lancefield's group C |
| Product Format |
freeze-dried |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol® |
no |
| Type Strain |
no |
| Medium |
ATCC® Medium 235: Todd-Hewitt broth
|
| Growth Conditions |
Temperature: 37.0°C |
| Name of Depositor |
Chugai Pharm. Co., Ltd. |
| U.S. Patent Number |
|
| Chain of Custody |
ATCC <<--Chugai Pharm. Co., Ltd.<<--M. Yoshioka <<--- F. Egami <<--- W. Maxted |
| References |
Ogawa H, et al. Method of production of anti-tumor substances. US Patent 3,786,141 dated Jan 15 1974
J. Biochem. 57: 64-74, 1965.
|
